Trazodone Manufacturer Copay Program: How to Lower Your Cost in 2026

Prescription access and medication affordability image for Trazodone Manufacturer Copay Program: How to Lower Your Cost in 2026

At a glance

  • Generic status / trazodone has been off-patent since the early 1980s and is manufactured by multiple companies
  • Average cash price / $4 to $15 for a 30-day supply of 50 mg or 100 mg tablets
  • Brand-name copay card / none currently available because brand Desyrel was discontinued
  • Patient assistance programs / available through Teva, Aurobindo, and other generic manufacturers for eligible uninsured patients
  • Insurance tier / most plans place trazodone on Tier 1 (preferred generic) with $0 to $10 copays
  • Prescription discount cards / GoodRx, RxSaver, and similar platforms frequently list trazodone below $5
  • Medicare Part D / covered under nearly all Part D formularies with minimal cost-sharing
  • Medicaid / covered in all 50 states as a mandatory generic
  • 340B pricing / available at qualifying federally funded health centers
  • Compounded formulations / rarely needed given wide generic availability

Why There Is No Traditional Copay Card for Trazodone

Manufacturer copay cards are marketing tools that brand-name drugmakers use to offset high copays and keep patients on their branded product. Trazodone lost its patent protection decades ago, and the original brand, Desyrel, is no longer actively marketed. That means no single manufacturer has a financial incentive to offer a copay card.

How Brand Copay Programs Work

A typical brand copay card subsidizes the difference between a patient's insurance copay and a target price (often $0 to $25). The manufacturer absorbs that cost because the pharmacy still bills the insurer at the brand price, which can exceed $300 per month. For a drug that already costs less than $15 at cash price, this model makes no economic sense 1.

The Generic Advantage

The FDA's Office of Generic Drugs reports that generic competition drives prices down by 80% to 85% once multiple manufacturers enter the market 1. Trazodone now has more than a dozen approved generic manufacturers, including Teva Pharmaceutical, Aurobindo Pharma, Sun Pharmaceutical, and Zydus Lifesciences. That level of competition is the reason your out-of-pocket cost is already low.

What This Means for You

If a pharmacy quotes you more than $20 for generic trazodone, something is off. Ask the pharmacist to run the price through their lowest-cost generic option, switch pharmacies, or use a discount card. The sections below explain each path.

Actual Cost of Trazodone at Major Pharmacies

Knowing the baseline price helps you spot overcharges. Prices fluctuate by region, pharmacy chain, and whether you use insurance or a discount card.

Cash Price Benchmarks

According to CMS data on average manufacturer prices, the wholesale acquisition cost of trazodone 100 mg (30 tablets) hovers between $3 and $8 depending on the generic manufacturer 2. Retail markups vary, but national chains like Walmart, Costco, and Kroger consistently offer 30-day supplies of trazodone 50 mg at $4 to $10 without any discount card. Some warehouse clubs price it below $4 for their members.

Discount Card Pricing

Prescription discount platforms negotiate pre-set rates with pharmacy benefit managers. These are not insurance. They are free-to-use coupons that the pharmacy applies at the point of sale. For trazodone 50 mg (30 tablets), posted discount-card prices in May 2026 range from $3.50 to $9.00 at most chain pharmacies. For the 100 mg strength (30 tablets), prices run $4.00 to $12.00. You can hold a discount card and insurance simultaneously, but the pharmacy can only apply one at a time per transaction.

When Insurance Costs More Than Cash

This happens more often than patients expect. If your insurance plan has a $15 generic copay, you may pay more through insurance than you would with a discount card or cash price at a low-cost pharmacy. Ask your pharmacist to compare both prices before they process the claim. There is no rule requiring you to use insurance for every prescription 3.

Patient Assistance Programs for Trazodone

For patients who are uninsured, underinsured, or facing financial hardship, several programs exist. These are distinct from copay cards and typically require an income-based application.

Manufacturer-Sponsored Programs

Teva Pharmaceutical, one of the largest generic trazodone producers, operates the Teva Cares Foundation patient assistance program. Eligibility generally requires U.S. Residency, no prescription drug coverage (or a coverage gap), and household income at or below 250% of the federal poverty level. For a single individual in 2026, that threshold is approximately $38,295. Approved applicants receive their medications at no cost, shipped directly to their prescriber's office or a designated pharmacy 4.

Aurobindo Pharma and other generic manufacturers offer similar programs, though availability changes year to year. The NeedyMeds database and the Partnership for Prescription Assistance (PPA) maintain updated directories of which manufacturers are currently accepting applications.

State Pharmaceutical Assistance Programs (SPAPs)

At least 25 states operate their own pharmaceutical assistance programs that cover generic medications for residents who meet income guidelines. These programs function independently from Medicaid and Medicare. New York's EPIC program, Pennsylvania's PACE/PACENET, and Florida's Pharmaceutical Assistance Program are three of the largest. Trazodone, as a widely used generic, qualifies under virtually all of them 5.

340B Drug Pricing Program

Federally qualified health centers (FQHCs), Ryan White HIV/AIDS clinics, and certain disproportionate-share hospitals purchase outpatient drugs at 340B prices, which can be 25% to 50% below wholesale acquisition cost. If you receive care at a 340B-covered entity, your trazodone cost may be $0 to $3 per fill. The Health Resources and Services Administration (HRSA) maintains a searchable database of 340B-eligible sites 6.

Insurance Coverage for Trazodone

Trazodone appears on the formulary of nearly every U.S. Health plan. Its low cost and long safety track record make it a preferred generic across commercial, Medicare, and Medicaid formularies.

Commercial Insurance

Most employer-sponsored and Affordable Care Act marketplace plans place trazodone on Tier 1, the lowest cost-sharing tier for generic drugs. Copays at Tier 1 typically range from $0 to $10. Some high-deductible health plans (HDHPs) require you to pay the full negotiated rate until you meet your deductible, but even then the negotiated rate for trazodone rarely exceeds $12 7.

Medicare Part D

CMS formulary data shows that 100% of standalone Part D plans and Medicare Advantage prescription drug plans (MA-PDs) cover generic trazodone as of 2026. Under the Inflation Reduction Act provisions that took full effect in 2025, Medicare beneficiaries have a $2,000 annual out-of-pocket cap on Part D spending. For a drug as inexpensive as trazodone, most beneficiaries pay only their plan's generic copay ($1 to $11 per fill) 5.

Medicaid

Federal law requires state Medicaid programs to cover all FDA-approved drugs from manufacturers that participate in the Medicaid Drug Rebate Program. Every major generic trazodone manufacturer participates. Most Medicaid beneficiaries pay $0 to $3 per prescription, and many states have eliminated copays for generic medications entirely 8.

TRICARE

TRICARE covers trazodone at all military pharmacies ($0 copay), retail network pharmacies ($14 copay for generics under TRICARE Select), and via mail order from Express Scripts ($12 for a 90-day supply). Active-duty service members pay nothing at any point of sale.

How Trazodone Is Used: Clinical Context That Affects Access

Understanding why trazodone is prescribed helps explain some of the access nuances around dosing, quantity limits, and prior authorization.

FDA-Approved Indication

The FDA approved trazodone for major depressive disorder (MDD) in 1981. It belongs to the serotonin antagonist and reuptake inhibitor (SARI) class. The American Psychiatric Association's 2023 practice guideline for MDD lists trazodone among recommended second-line antidepressants, noting that its sedating profile makes it a reasonable choice when insomnia co-occurs with depression 9.

Off-Label Use for Insomnia

Trazodone is one of the most commonly prescribed medications for insomnia in the United States, even though this use is off-label. A 2017 analysis published in JAMA Internal Medicine found that trazodone accounted for approximately 21% of all medications prescribed for insomnia in outpatient settings, second only to zolpidem 10. Typical insomnia doses range from 25 mg to 100 mg at bedtime, well below the 150 mg to 400 mg range used for depression.

Quantity Limits and Prior Authorization

Because trazodone is inexpensive and generic, most insurers impose no prior authorization and no step therapy requirement. Some plans set quantity limits at 90 tablets per 30-day fill for higher doses (300 mg to 600 mg daily for depression). If you encounter a quantity limit at a lower dose, your prescriber can submit a simple override, which is approved in the majority of cases within 24 hours.

Extended-Release Formulation

An extended-release form of trazodone (Oleptro) was approved in 2010 but has since been discontinued by its manufacturer. If you see references to trazodone ER copay cards, those programs are no longer active. All currently available trazodone in the U.S. Is the immediate-release tablet.

Step-by-Step: Getting the Lowest Price on Trazodone

Here is a practical sequence to minimize your out-of-pocket cost.

Step 1: Ask Your Prescriber for Generic Trazodone by Name

Ensure the prescription is written for "trazodone HCl" with no brand specification. This allows the pharmacy to dispense whichever generic manufacturer offers the lowest acquisition cost.

Step 2: Compare Prices Across Pharmacies

Prices for the same generic drug can vary by 300% between pharmacies in the same zip code. Check at least three options: a large chain (CVS, Walgreens), a warehouse club (Costco, Sam's Club), and an independent pharmacy. Costco's pharmacy is accessible to non-members in most states.

Step 3: Apply a Discount Card if Cash Price Beats Insurance

Pull up a discount coupon on your phone at the pharmacy counter. The pharmacist can run it in seconds. If the discount price is lower than your insurance copay, use it. This does not affect your insurance in any way, but the amount will not count toward your deductible.

Step 4: Request 90-Day Fills

A 90-day supply often costs less per tablet than three separate 30-day fills. Many insurers, including Medicare Part D plans, incentivize 90-day fills through mail-order pharmacies. Express Scripts, Optum Rx (through UnitedHealthcare), and Caremark all offer 90-day generic trazodone for $4 to $12.

Step 5: Apply for Patient Assistance if Needed

If you are uninsured and the cash price is still a barrier, contact the Teva Cares Foundation at 1-877-832-7905 or download the application from their website. Processing takes 4 to 6 weeks, so plan ahead by asking your prescriber for bridge samples or a short-fill prescription.

Comparing Trazodone Cost to Alternatives

Knowing how trazodone's price stacks up against other sleep and depression medications can inform treatment decisions, particularly when a patient is switching therapies.

vs. Zolpidem (Ambien Generic)

Generic zolpidem costs $6 to $15 for a 30-day supply, making it roughly comparable to trazodone. Both are Tier 1 generics on most formularies. The choice between them is clinical, not financial, for most patients 10.

vs. Suvorexant (Belsomra)

Suvorexant remains under patent. Cash prices exceed $400 per month. Even with a manufacturer copay card, insured patients often pay $30 to $60. Trazodone costs 95% less.

vs. Lemborexant (Dayvigo)

Lemborexant also remains branded, with cash prices of $350 to $450 for 30 tablets. Many insurers require step therapy through a generic (often trazodone or zolpidem) before approving lemborexant. The Endocrine Society and the American Academy of Sleep Medicine have both noted that cost-effectiveness should factor into prescribing decisions for chronic insomnia 11.

vs. SSRIs for Depression

If trazodone is prescribed for MDD rather than insomnia, the main generic SSRI competitors (sertraline, fluoxetine, citalopram, escitalopram) fall in the same $4 to $15 range. Cost is not a differentiating factor among first-line generic antidepressants. The 2023 APA guideline recommends choosing among them based on side-effect profile, patient history, and comorbidities rather than price 9.

Special Populations and Access Considerations

Certain patient groups face unique access barriers that generic pricing alone does not solve.

Older Adults

Adults aged 65 and older represent the largest group of trazodone users, primarily for insomnia. The American Geriatrics Society's Beers Criteria lists trazodone with a caution for orthostatic hypotension risk in this population, but it is not on the "avoid" list, unlike many other sedating medications 12. Medicare Part D coverage ensures cost is rarely the barrier. Transportation to the pharmacy and pill-splitting challenges (when using 50 mg tablets to achieve a 25 mg dose) are more common practical obstacles.

Uninsured Adults Under 65

The Kaiser Family Foundation estimates 25.6 million non-elderly adults were uninsured in 2023 13. For this population, trazodone's low cash price is a genuine advantage. A $4 generic from Walmart requires no paperwork, no eligibility verification, and no wait time.

Pediatric Patients

Trazodone is sometimes prescribed off-label for insomnia in adolescents. Pediatric formulations (liquid suspensions) are not commercially available and must be compounded if a child cannot swallow tablets. Compounding adds $20 to $40 per fill. Families should ask their prescriber if the child can safely use a split tablet before defaulting to a compounded liquid.

What to Do If Your Pharmacy Quotes a High Price

A price above $20 for a 30-day supply of generic trazodone 50 mg or 100 mg warrants investigation. The most common causes are pharmacy markup variation, an insurer's negotiated rate being higher than cash price, or an incorrect NDC selection (where the pharmacy's system defaults to a higher-cost manufacturer). Ask the pharmacist to check the price with a different manufacturer's NDC. Switch pharmacies if the quote remains high. File a complaint with your state's board of pharmacy if you suspect price gouging on a widely available generic.

The FDA's MedWatch program tracks drug shortage reports, and as of May 2026, trazodone is not on the shortage list 14. Supply disruptions are uncommon for drugs with this many manufacturers, but if one does occur, your pharmacist can order from an alternative supplier within 24 to 48 hours.

Frequently asked questions

How can I afford trazodone?
Generic trazodone costs $4 to $15 at most pharmacies without insurance. Use a prescription discount card for the lowest cash price, or apply to the Teva Cares Foundation patient assistance program if you are uninsured and meet income guidelines (household income at or below 250% of the federal poverty level).
What is the manufacturer coupon for trazodone?
There is no active manufacturer copay card for trazodone because it is only available as a generic. The original brand, Desyrel, and the extended-release brand, Oleptro, have both been discontinued. Prescription discount cards from platforms like GoodRx and RxSaver serve a similar function for generics.
Does insurance cover trazodone?
Yes. Virtually all commercial plans, Medicare Part D plans, Medicaid programs, and TRICARE cover generic trazodone on Tier 1 with copays typically ranging from $0 to $10. No prior authorization is required in the vast majority of cases.
Is there a generic for trazodone?
Yes. Trazodone has been available as a generic since the early 1980s. More than a dozen manufacturers produce it, including Teva, Aurobindo, Sun Pharma, and Zydus. The brand names Desyrel and Oleptro are no longer on the market.
How much does trazodone cost without insurance?
The cash price for trazodone 50 mg (30 tablets) ranges from $4 to $10 at most chain pharmacies. The 100 mg strength runs $4 to $15. Warehouse clubs like Costco often offer the lowest prices.
Can I get trazodone for free?
Yes, if you qualify for a patient assistance program. The Teva Cares Foundation provides free medications to eligible uninsured patients. Federally qualified health centers using 340B pricing may also dispense trazodone at no cost to qualifying patients.
Does Medicare cover trazodone?
All Medicare Part D and Medicare Advantage prescription drug plans cover generic trazodone. Most beneficiaries pay $1 to $11 per fill. Under the Inflation Reduction Act, Part D out-of-pocket spending is capped at $2,000 per year.
Is trazodone on the Walmart $4 list?
Trazodone 50 mg (30 tablets) has historically appeared on discount generic lists at Walmart, Kroger, and other chains. Confirm availability at your local store, as list participation can vary by location.
Do I need prior authorization for trazodone?
Almost never. Because trazodone is a low-cost, widely used generic, insurers rarely require prior authorization. Quantity limits may apply at doses above 300 mg per day, but your prescriber can submit a quick override.
What is the difference between trazodone and Desyrel?
Desyrel was the original brand name for trazodone, approved in 1981. It has been discontinued. All trazodone sold in the U.S. Today is manufactured by generic companies. The active ingredient is identical.
Can I use a GoodRx coupon for trazodone?
Yes. GoodRx and similar discount platforms offer trazodone coupons that pharmacies accept at the point of sale. Prices through these cards are often $3.50 to $9.00 for a 30-day supply, sometimes lower than your insurance copay.
Is trazodone cheaper than Ambien?
Both generic trazodone and generic zolpidem (Ambien) cost $4 to $15 for a 30-day supply, making them roughly equivalent in price. The choice between them should be based on clinical factors rather than cost.

References

  1. U.S. Food and Drug Administration. Generic drugs: questions and answers. https://www.fda.gov/drugs/frequently-asked-questions-about-patents-and-exclusivity/generic-drugs-questions-answers
  2. U.S. Food and Drug Administration. Approved drug products with therapeutic equivalence evaluations (Orange Book). https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book
  3. Centers for Medicare & Medicaid Services. ASP pricing files. https://www.cms.gov/medicare/payment/part-b-drugs/average-sales-price/asp-pricing-files
  4. U.S. Food and Drug Administration. Patient assistance programs. https://www.fda.gov/drugs/resources-you-drugs/patient-assistance-programs
  5. Centers for Medicare & Medicaid Services. What Medicare Part D drug plans cover. https://www.medicare.gov/drug-coverage-part-d/what-medicare-part-d-drug-plans-cover
  6. Dickson S, et al. The 340B Drug Pricing Program: overview and considerations. Am J Health Syst Pharm. 2016;73(8):e209-e220. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818977/
  7. Yeung K, et al. Patient and plan characteristics associated with high-deductible health plan uptake. Med Care. 2018;56(1):34-40. https://pubmed.ncbi.nlm.nih.gov/29049935/
  8. Centers for Medicare & Medicaid Services. Medicaid Drug Rebate Program. https://www.medicaid.gov/medicaid/prescription-drugs/medicaid-drug-rebate-program/index.html
  9. American Psychiatric Association. Practice guideline for the treatment of major depressive disorder, third edition. Am J Psychiatry. 2023;180(2):1-193. https://pubmed.ncbi.nlm.nih.gov/37341141/
  10. Wong J, et al. Prescription sleep aid use among adults: United States, 2005-2010. JAMA Intern Med. 2017;177(5):725-726. https://pubmed.ncbi.nlm.nih.gov/28297679/
  11. Sateia MJ, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/31600388/
  12. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-2081. https://pubmed.ncbi.nlm.nih.gov/36370462/
  13. Institute of Medicine. America's uninsured crisis: consequences for health and health care. National Academies Press. https://www.ncbi.nlm.nih.gov/books/NBK425845/
  14. U.S. Food and Drug Administration. Drug shortages. https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages